A detailed history of Biltmore Family Office, LLC transactions in Danaher Corp stock. As of the latest transaction made, Biltmore Family Office, LLC holds 1,727 shares of DHR stock, worth $405,931. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,727
Previous 1,811 4.64%
Holding current value
$405,931
Previous $452,000 6.19%
% of portfolio
0.08%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $20,097 - $23,583
-84 Reduced 4.64%
1,727 $480,000
Q2 2024

Aug 07, 2024

BUY
$235.51 - $267.98 $49,457 - $56,275
210 Added 13.12%
1,811 $452,000
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $40,873 - $46,626
182 Added 12.83%
1,601 $399,000
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $56,638 - $64,538
243 Added 20.66%
1,419 $352,000
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $2,157 - $2,493
-9 Reduced 0.76%
1,176 $296,000
Q4 2022

Feb 07, 2023

SELL
$241.42 - $282.29 $4,104 - $4,798
-17 Reduced 1.41%
1,185 $314,000
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $2,470 - $15,074
10 Added 0.84%
1,202 $311,000
Q2 2022

Aug 04, 2022

SELL
$237.11 - $299.66 $16,360 - $20,676
-69 Reduced 5.47%
1,192 $302,000
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $84,411 - $95,083
-289 Reduced 18.65%
1,261 $415,000
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $78,668 - $96,072
289 Added 22.92%
1,550 $472,000
Q2 2020

Aug 05, 2020

BUY
$128.7 - $176.83 $162,290 - $222,982
1,261 New
1,261 $223,000
Q4 2019

Feb 05, 2020

SELL
$133.47 - $153.48 $196,601 - $226,076
-1,473 Closed
0 $0
Q3 2019

Oct 16, 2019

SELL
$135.4 - $146.47 $27,486 - $29,733
-203 Reduced 12.11%
1,473 $213,000
Q2 2019

Jul 31, 2019

BUY
$124.88 - $143.73 $209,298 - $240,891
1,676 New
1,676 $240,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Biltmore Family Office, LLC Portfolio

Follow Biltmore Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.